behavior/neurological
• male homozygotes display decreased sensitivity to the depressing effects of LPS and IL-1beta on sickness behavior, with attenuated social exploration, immobility and body weight loss relative to wild-type males
|
• in response to i.p. injection of IL-1beta (1.0 g/mouse) and LPS (2.5 g/mouse), male homozygotes exhibit a shorter duration of immobility relative to wild-type males
|
• in response to i.p. injection of IL-1beta (1.0 g/mouse) and LPS (2.5 g/mouse), male homozygotes show an attenuated reduction in social interaction relative to wild-type males
• notably, i.c.v. administration of IL-1beta and LPS depresses social exploration only in wild-type mice, whereas mutants remain unaffected
|
growth/size/body
• in response to i.p. injection of IL-1beta (1.0 g/mouse) and LPS (2.5 g/mouse), male homozygotes show an attenuated body weight loss relative to wild-type males
|
neoplasm
• in response to i.p. injection with pristane oil, homozygotes exhibit delayed and reduced ascite development, fail to display changes in the cellular content of ascitic fluids, and do not develop any clinically or histologically detectable plasmacytomas
• occasional mature plasma cells with atypical or anaplastic features are detected in the ascitic fluid and mesenteric tissues of some homozygotes, indicating initial plasma cell transformation
|
immune system
• 8- to 10-week-old male homozygotes are less affected by peripheral and central injections of IL-1beta and LPS than wild-type male littermates
|
• pristane-treated homozygotes exhibit a reduced frequency of B cell differentiation and plasma cell formation, with rare morphological signs of activation and scant B-cell blast aggregates
|
• in response to i.p. injection with pristane oil, homozygotes show an attenuated inflammatory response, with reduced peritoneal granuloma formation, reduced histiocyte and fibroblast number in granulomatous tissue, and only rare signs of B cell activation
|
hematopoietic system
• pristane-treated homozygotes exhibit a reduced frequency of B cell differentiation and plasma cell formation, with rare morphological signs of activation and scant B-cell blast aggregates
|
cellular
• pristane-treated homozygotes exhibit a reduced frequency of B cell differentiation and plasma cell formation, with rare morphological signs of activation and scant B-cell blast aggregates
|